Our study indicated Nox4 and IRS1 as the therapeutic targets of tendinopathy; however, further research is needed to clarify the functional mechanism of Nox4 and IRS1 in chondro-osteogenesis in tendinopathy. The gene discussed is IRS1; the disease is disease of the tendon.